Xeris Biopharma Reports Fourth Quarter and Full-year 2021 Financial Results and Recent Events

Go back to Xeris Biopharma Reports Fourth Quarter and Full-year 2021 Financial Results and Recent Events
(NASDAQ: XERS) Delayed: 8.65 +0.45 (5.49%)
Previous Close $8.20    52 Week High
Open $8.28    52 Week Low
Day High $8.68    P/E N/A 
Day Low $8.16    EPS
Volume 261,247